MedTrace Logo

Comparison of Conventional Dialysis and the Allient System

NCT00788905 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-03-29

No results posted yet for this study

Summary

The purpose of the study to determine whether the level of inflammation may be decreased, the lifespan of red blood cells increased and the clearance of waste products in the blood improved through the use of the Allient System as compared to conventional hemodialysis.

Conditions

Interventions

DEVICE

Allient System

The Allient System uses a different type of blood pump and a lower volume of dialysate.

Sponsors & Collaborators

  • Renal Solutions, Inc.

    collaborator INDUSTRY

  • Renal Research Institute

    lead OTHER

Principal Investigators

  • Nathan W. Levin, MD · Renal Research Institute

  • Peter Kotanko, MD · Renal Research Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-02-28
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00788905 on ClinicalTrials.gov